XOMA Corporation
(NASDAQ : XOMA)

( )
XOMA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
TSROTESARO, Inc.
-0.27%73.4614.4%$569.48m
AMGNAmgen Inc.
-1.57%187.101.2%$545.46m
GILDGilead Sciences, Inc.
-0.43%64.840.9%$536.21m
CELGCelgene Corporation
-2.20%66.631.2%$484.48m
BIIBBiogen Inc.
-5.86%294.751.3%$368.52m
ILMNIllumina, Inc.
0.87%313.583.5%$340.51m
REGNRegeneron Pharmaceuticals, Inc.
-1.73%369.002.6%$264.69m
VRTXVertex Pharmaceuticals Incorporated
-1.65%163.431.9%$212.48m
AAgilent Technologies, Inc.
0.22%68.001.5%$210.52m
ALXNAlexion Pharmaceuticals, Inc.
-3.23%105.992.0%$152.62m
INCYIncyte Corporation
-0.86%64.262.5%$97.13m
EXASExact Sciences Corporation
1.03%67.8025.3%$97.02m
BLUEBluebird Bio, Inc.
-1.09%103.4314.4%$90.69m
SRPTSarepta Therapeutics, Inc.
-6.64%108.0215.4%$84.06m
NKTRNektar Therapeutics
4.63%35.745.5%$83.18m

Company Profile

XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Berkeley, CA.